Search
NEXAVAR 200 MG, Comprimé pelliculé
Details
| --- | Description |
|---|---|
| Pack | Boîte de 60 |
| Strength (Dosage) | 200 MG |
| Laboratory | BAYER S.A |
| Ingredients | Sorafénib |
| Therapeutic class | Antinéoplasique, inhibiteur de multikinase |
| ATC code | L01XE05 |
| PPH | $2,074.50 |
| PPV | $2,115.20 |
| Refundable | Yes |
| Refund base | $2,115.20 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Carcinome hépatocellulaire Le sorafénib est indiqué dans le traitement du carcinome hépatocellulaire. Carcinome rénal Le sorafénib est indiqué dans le traitement du carcinome rénal avancé après échec d’un traitement préalable à base d’interféron alfa ou d’interleukine 2 ou chez des patients pour lesquels ces traitements sont considérés comme inadaptés. Carcinome thyroïdien différencié Le sorafénib est indiqué dans le traitement du carcinome thyroïdien progressif, localement avancé ou métastatique, différencié (cancer papillaire/folliculaire/à cellules de Hürthle), réfractaire à l’ioderadioactif. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem